Bin-Chi Liao - Concepedia

Author

Bin-Chi Liao

National Taiwan University Hospital ORCID

Also Known As

B. Liao, B.-C. Liao, BIN-CHI LIAO, Baihao Liao, Baodong Liao, Bin-Chi Liao, Binchi Liao

Publications

Citations

H-Index

Concepts

All Affiliations

National Taiwan University Hospital National Taiwan University

About

Bin-Chi Liao is an author at National Taiwan University Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	360
2	Pathology	3	3	320
3	Health Sciences	2	2	40
4	Immunology	2	2	130
5	Gastroenterology	1	1	21

Bin-Chi Liao

Publications

624

Citations

H-Index

Page 1

	Year	Citations
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non–Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis Bin-Chi Liao, Jih‐Hsiang Lee, Chia‐Chi Lin, Journal of Thoracic Oncology MedicineReceptor Tyrosine KinaseLeptomeningeal CarcinomatosisPathologyCancer Cell Biology	2015	190
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Ching‐Yao Yang, Wei‐Yu Liao, Chao‐Chi Ho, European Journal of Cancer MedicineImmunologyPathologyCell DeathBronchial Neoplasm	2019	89
Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung Cancer Chia‐Chi Hsu, Bin-Chi Liao, Wei‐Yu Liao, Journal of Thoracic Oncology	2019	82
Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis Hsiang‐Fong Kao, Bin-Chi Liao, Yenlin Huang, Clinical Cancer Research	2022	63
Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan Shu‐Yung Lin, Ching‐Yao Yang, Bin-Chi Liao, Journal of Cancer	2018	55
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma Wan‐Teck Lim, Hsiang‐Fong Kao, Lisda Suteja, Nature Communications Cancer ImmunosurveillanceDual Pd-1/ctla-4 BlockadeBiomarker AnalysisEpstein-barr VirusPd-l1 Expression	2023	41
CD73 Is Regulated by the EGFR-ERK Signaling Pathway in Non-small Cell Lung Cancer Sebastian Griesing, Bin-Chi Liao, James Chih‐Hsin Yang Anticancer Research	2021	26
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib Ching‐Yao Yang, Wei‐Yu Liao, Chao‐Chi Ho, The Oncologist	2020	24
Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis Jhe‐Cyuan Guo, Chin‐Chen Chang, Chung-Yi Yang, Medical Oncology Surgical OncologyMedical ImagingGastrointestinal OncologyMedicineAbdominal Imaging	2017	21
Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma Bin-Chi Liao, Yu‐Yun Shao, Ho‐Min Chen, Clinical Lung Cancer Comparative EffectivenessMedicineBronchial NeoplasmCancer TreatmentOncology	2014	19

Page 1